Pettiti Gianluca's Form 4 filing
Thermo Fisher Scientific Inc. (TMO) · filed Sep 1, 2026
- Accession no.
- 0000097745-26-000162
- Filed
- Sep 1, 2026, 4:10 PM ET
- Trade date
- Aug 28-31, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 7 non-derivative transactions and 1 derivative transaction. Open-market sales total $2.54M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Pettiti GianlucaCIK 0001844600 | Officer (President & COO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 28, 2026 | Common Stock | FTax withholdingDisposed | −212.256 | $622.18 | −$132,061.44 | 24,438.576 | Direct | |
| Aug 28, 2026 | Common Stock | FTax withholdingDisposed | −303.639 | $622.18 | −$188,918.11 | 24,134.937 | Direct | |
| Aug 28, 2026 | Common Stock | FTax withholdingDisposed | −249.003 | $622.18 | −$154,924.69 | 23,885.934 | Direct | |
| Aug 28, 2026 | Common Stock | FTax withholdingDisposed | −269.794 | $622.18 | −$167,860.43 | 23,616.14 | Direct | |
| Aug 31, 2026 | Common Stock | SSaleDisposed | −400 | $614.38 | −$245,752 | 23,216.14 | Direct | |
| Aug 31, 2026 | Common Stock | MOption exerciseAcquired | +3,733 | $309.63 | +$1,155,848.79 | 26,949.14 | Direct | |
| Aug 31, 2026 | Common Stock | SSaleDisposed | −3,733 | $614.38 | −$2,293,480.54 | 23,216.14 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 31, 2026 | Common Stock | MOption exerciseDisposed | −3,733 | $0.00 | $0 | 7,467 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.